Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression

Open Access

Peer-reviewed

Research Article

John Castle,

Affiliation Clinical and Experimental Pharmacology, Cancer Research UK Manchester Institute; Manchester, United Kingdom

http://orcid.org/0000-0001-8213-9775

⨯
Karen Morris,

Affiliation Clinical and Experimental Pharmacology, Cancer Research UK Manchester Institute; Manchester, United Kingdom
⨯
Susan Pritchard,

Affiliation Department of Histopathology, University Hospital of South Manchester; Manchester, United Kingdom
⨯
Cliona C. Kirwan

* E-mail: cliona.kirwan@manchester.ac.uk

Affiliation Division of Molecular and Clinical Cancer Sciences, University of Manchester; Department of Academic Surgery, University Hospital of South Manchester, Manchester, United Kingdom
⨯

Reader Comments (0)

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Blood
Is the Subject Area "Blood" applicable to this article?

Thanks for your feedback.
Cell staining
Is the Subject Area "Cell staining" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Immunocytochemistry
Is the Subject Area "Immunocytochemistry" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Estrogens
Is the Subject Area "Estrogens" applicable to this article?

Thanks for your feedback.